anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.12.16 | Roche overweight | JP Morgan Chase & Co. | |
| 30.11.16 | Roche buy | Citigroup Corp. | |
| 30.11.16 | Roche buy | Deutsche Bank AG | |
| 30.11.16 | Novartis Hold | Deutsche Bank AG | |
| 29.11.16 | Roche Strong Buy | S&P Capital IQ | |
| 29.11.16 | Roche overweight | JP Morgan Chase & Co. | |
| 18.11.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 18.11.16 | Roche Hold | Baader Bank | |
| 11.11.16 | Roche buy | Jefferies & Company Inc. | |
| 08.11.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.11.16 | Roche overweight | Morgan Stanley | |
| 04.11.16 | Roche buy | Goldman Sachs Group Inc. | |
| 03.11.16 | Roche buy | Citigroup Corp. | |
| 02.11.16 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.10.16 | Novartis buy | Baader Wertpapierhandelsbank | |
| 26.10.16 | Novartis Outperform | Credit Suisse Group | |
| 26.10.16 | Novartis Hold | Deutsche Bank AG | |
| 26.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 25.10.16 | Novartis Hold | S&P Capital IQ | |
| 24.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 21.10.16 | Roche buy | Deutsche Bank AG | |
| 21.10.16 | Roche Hold | Kepler Cheuvreux | |
| 21.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.10.16 | Roche Hold | HSBC | |
| 20.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.10.16 | Roche Outperform | Bernstein Research | |
| 19.10.16 | Novartis Outperform | Bernstein Research | |
| 19.10.16 | Novartis Underweight | Morgan Stanley | |
| 19.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.10.16 | Novartis Hold | Deutsche Bank AG | |
| 13.10.16 | Roche overweight | Morgan Stanley | |
| 13.10.16 | Novartis buy | Jefferies & Company Inc. | |
| 13.10.16 | Roche buy | Jefferies & Company Inc. | |
| 12.10.16 | Roche buy | Deutsche Bank AG | |
| 10.10.16 | Novartis Hold | Deutsche Bank AG | |
| 10.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 10.10.16 | Roche overweight | JP Morgan Chase & Co. | |
| 10.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 10.10.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. |